Latest News

Nova Mentis Re-Appoints Robert W.E. Laurie as Advisory Board Chair and Psychedelics Regulatory Advisor

 

Vancouver, British Columbia – July 08, 2020 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFD) (“NOVA” or the “Company”) is pleased to announce  Mr. Robert W.E. Laurie has been re-appointed Advisory Board Chair and additionally appointed  Psychedelics Regulatory Advisor.

Robert W.E. Laurie is an international lawyer, qualified in England and called to the British Columbia Bar. Mr. Laurie founded Ad Lucem Law Corporation in Vancouver in 2013 and his legal practice focuses on commercial business, government, regulatory issues, plus charter and constitutional legalities surrounding cannabis and psychedelic plant medicines.

Mr. Laurie serves as a Board Advisor to the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada, Steve DeAngelo’s Last Prisoner Project, SPORE Denver and is Legal Advisor to the Heroic Hearts Project UK. He is one of the Founding Partners with Dr. Dennis McKenna of the McKenna Academy of Natural Philosophy. He serves as a Director with Jay DeMerit and Ashleigh McIvor’s Rise and Shine Foundation and Rex Weyler’s Ecuador Amazon Restoration Project. Mr. Laurie holds an M.A. (Hons) Juris from the University of Oxford (St. Edmund Hall) and B.A. (Hons) in Political Science and International Relations from the University of British Columbia.

Mr. Laurie has been working and advocating tirelessly as a lawyer to improve medical patient access to cannabis, psychedelic and sacred plant medicines and to facilitate the reform of drug laws for the betterment of society. He and his legal practice, Ad Lucem Law Corporation, recently joined Dr. Bruce Tobin’s Charter litigation team and the TheraPsil Alliance, who are challenging in Federal Court the constitutional validity of the government’s absolute prohibition concerning compassionate medical access to psilocybin. His goal is to help provide more options for doctors and treatments for patients dealing with end-of-life anxiety and depression, and other types of treatment-resistant depression, addiction, and PTSD.

“We are excited that Robert will continue his role as Chair of Nova Mentis’ Advisory Board along with the added responsibility of Psychedelics Regulatory Advisor,” said Will Rascan, CEO & President of NOVA.  “There are very few individuals with Robert’s in-depth experience and contacts in both the psychedelics and cannabis sectors.  With Robert having joined Dr. Bruce Tobin’s Charter litigation team, he brings a unique perspective which is evident in his recent Psyched2020 webinar presentation.”

Click link to view: https://www.youtube.com/watch?v=4fb8PDA-X7g

 

About Nova Mentis Life Science Corp.

Nova Mentis Life Science Corp. (formerly Liberty Leaf Holdings Ltd.) is a Canadian-based, public company whose focus is to build and support a diversified portfolio of health and wellness businesses. Key holdings include its wholly-owned subsidiary, Nova Mentis Biotech Corp., a R&D driven company focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes – Just Kush Enterprises, a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich Kush dominant cultivars cured to perfection.

For further information on the Company please visit https://www.libleaf.com or email info@libleaf.com.

 

On Behalf of the Board

Will Rascan, President & CEO
Nova Mentis Life Science Corp.

Phone: 778-819-0244
Toll Free: 1-833-542-5323
Twitter: @novamentislsc
Instagram: @novamentislsc
Facebook: @novamentislsc

 

 

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release contains statements that constitute “forward-looking statements.” Such forward looking statements involve known and unknown risks, uncertainties and other factors that may cause Liberty Leaf’s actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “potential” and similar expressions, or that events or conditions “will,” “would,” “may,” “could” or “should” occur.

 

Get Started

Whether you are an investor seeking to include the cannabis industry in your portfolio, or an entrepreneur with a start-up or a strong business idea for the legal cannabis space, Liberty Leaf has the expertise and financial resources to build your portfolio or take your enterprise to the next level.